Jorey Chernett Acquires 20,000 Shares of AirSculpt Technologies (NASDAQ:AIRS) Stock

AirSculpt Technologies, Inc. (NASDAQ:AIRS) major shareholder Jorey Chernett bought 20,000 shares of AirSculpt Technologies stock in a transaction that occurred on Tuesday, April 14th. The shares were acquired at an average price of $2.60 per share, with a total value of $52,000.00. Following the completion of the transaction, the insider owned 7,013,761 shares of the company’s stock, valued at $18,235,778.60. This represents a 0.29% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Jorey Chernett also recently made the following trade(s):

• On Tuesday, April 7th, Jorey Chernett bought 60,000 shares of AirSculpt Technologies stock. The shares were acquired at an average price of $2.93 per share, with a total value of $175,800.00.
• On Friday, April 3rd, Jorey Chernett bought 90,000 shares of AirSculpt Technologies stock. The shares were acquired at an average price of $2.82 per share, with a total value of $253,800.00.
• On Monday, March 23rd, Jorey Chernett bought 50,000 shares of AirSculpt Technologies stock. The shares were acquired at an average price of $2.91 per share, with a total value of $145,500.00.
• On Friday, March 20th, Jorey Chernett bought 40,000 shares of AirSculpt Technologies stock. The shares were acquired at an average price of $2.77 per share, with a total value of $110,800.00.
• On Thursday, March 19th, Jorey Chernett bought 77,702 shares of AirSculpt Technologies stock. The shares were acquired at an average price of $2.64 per share, with a total value of $205,133.28.
• On Tuesday, March 17th, Jorey Chernett bought 83,000 shares of AirSculpt Technologies stock. The shares were acquired at an average price of $2.56 per share, with a total value of $212,480.00.
• On Monday, March 16th, Jorey Chernett bought 105,848 shares of AirSculpt Technologies stock. The shares were acquired at an average price of $2.43 per share, with a total value of $257,210.64.
• On Wednesday, March 11th, Jorey Chernett bought 88,000 shares of AirSculpt Technologies stock. The shares were acquired at an average price of $2.15 per share, with a total value of $189,200.00.
• On Friday, March 6th, Jorey Chernett bought 45,600 shares of AirSculpt Technologies stock. The shares were acquired at an average price of $2.00 per share, with a total value of $91,200.00.
• On Wednesday, March 4th, Jorey Chernett bought 30,000 shares of AirSculpt Technologies stock. The shares were acquired at an average price of $1.87 per share, with a total value of $56,100.00.

AirSculpt Technologies Price Performance

AirSculpt Technologies stock traded up $0.12 during midday trading on Wednesday, hitting $2.74. 339,425 shares of the company’s stock were exchanged, compared to its average volume of 2,569,510. AirSculpt Technologies, Inc. has a 52-week low of $1.51 and a 52-week high of $12.00. The stock has a 50-day moving average price of $2.33 and a two-hundred day moving average price of $4.13. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.55 and a current ratio of 0.55. The company has a market cap of $192.95 million, a P/E ratio of -14.45 and a beta of 2.22.

AirSculpt Technologies (NASDAQ:AIRS) last posted its earnings results on Tuesday, March 31st. The company reported $0.02 EPS for the quarter, topping the consensus estimate of ($0.03) by $0.05. AirSculpt Technologies had a negative return on equity of 5.01% and a negative net margin of 7.68%.The business had revenue of $33.44 million during the quarter, compared to analysts’ expectations of $34.93 million. During the same period in the previous year, the business earned ($0.09) earnings per share. The firm’s revenue was down 14.8% on a year-over-year basis. On average, equities research analysts forecast that AirSculpt Technologies, Inc. will post -0.01 earnings per share for the current year.

Institutional Investors Weigh In On AirSculpt Technologies

A number of hedge funds and other institutional investors have recently modified their holdings of AIRS. Virtu Financial LLC bought a new stake in shares of AirSculpt Technologies in the 4th quarter valued at about $30,000. Millennium Management LLC bought a new stake in shares of AirSculpt Technologies in the 4th quarter valued at about $33,000. Aigen Investment Management LP bought a new stake in shares of AirSculpt Technologies in the 4th quarter valued at about $36,000. Wells Fargo & Company MN lifted its stake in shares of AirSculpt Technologies by 49.9% in the 4th quarter. Wells Fargo & Company MN now owns 19,275 shares of the company’s stock valued at $38,000 after acquiring an additional 6,420 shares during the last quarter. Finally, BNP Paribas Financial Markets lifted its stake in shares of AirSculpt Technologies by 239.5% in the 3rd quarter. BNP Paribas Financial Markets now owns 5,952 shares of the company’s stock valued at $48,000 after acquiring an additional 4,199 shares during the last quarter. Institutional investors own 91.54% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have issued reports on AIRS. Wall Street Zen raised AirSculpt Technologies from a “sell” rating to a “hold” rating in a research note on Sunday, April 5th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of AirSculpt Technologies in a research note on Monday, December 29th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Reduce” and a consensus target price of $6.00.

AirSculpt Technologies Company Profile

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.